Request Sample Inquiry
Next-gen Biomanufacturing Market

Next-gen Biomanufacturing Market

Next-gen Biomanufacturing Market - Global Industry Assessment & Forecast

Number Of Pages # Pages:

190

Base Year:

2023

Date

Jun - 2024

Format:

PDF XLS PPT

Report Code:

VMR-2514

Segments Covered
  • By Workflow Type By Workflow Type Continuous Upstream Biomanufacturing Workflow, Single-Use Upstream Biomanufacturing Workflow, Downstream Biomanufacturing Workflow
  • By Application By Application Monoclonal Antibodies, Vaccines, Hormones, Recombinant Proteins, Other Applications
  • By End User By End User Biopharmaceutical Companies, Research Institutions, CMOs/CDMOs
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base YearBase Year: 2023
Forecast YearsForecast Years: 2024 - 2032
Historical YearsHistorical Years: 2018 - 2022
Revenue 2023Revenue 2023: USD 20.5 Billion
Revenue 2032Revenue 2032: USD 39.4 Billion
Revenue CAGRRevenue CAGR (2024 - 2032): 7.5%
Fastest Growing Region Fastest Growing Region (2024 - 2032) Asia Pacific
Largest Region Largest Region (2023): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst

Next-gen Biomanufacturing Market Segment Analysis

  • Next-gen Biomanufacturing Workflow Type Outlook (Revenue, USD Million, 2018 - 2030)
    • Continuous Upstream Biomanufacturing Workflow
    • Single-Use Upstream Biomanufacturing Workflow
    • Downstream Biomanufacturing Workflow
  • Next-gen Biomanufacturing Application Outlook (Revenue, USD Million, 2018 - 2030)
    • Monoclonal Antibodies
    • Vaccines
    • Hormones
    • Recombinant Proteins
    • Other Applications
  • Next-gen Biomanufacturing End User Outlook (Revenue, USD Million, 2018 - 2030)
    • Biopharmaceutical Companies
    • Research Institutions
    • CMOs/CDMOs
  • Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
    • North America
      • North America Next-gen Biomanufacturing Market, by Workflow Type
        • Continuous Upstream Biomanufacturing Workflow
        • Single-Use Upstream Biomanufacturing Workflow
        • Downstream Biomanufacturing Workflow
      • North America Next-gen Biomanufacturing Market, by Application
        • Monoclonal Antibodies
        • Vaccines
        • Hormones
        • Recombinant Proteins
        • Other Applications
      • North America Next-gen Biomanufacturing Market, by End User
        • Biopharmaceutical Companies
        • Research Institutions
        • CMOs/CDMOs
      • U.S.
        • U.S. Next-gen Biomanufacturing Market, by Workflow Type
          • Continuous Upstream Biomanufacturing Workflow
          • Single-Use Upstream Biomanufacturing Workflow
          • Downstream Biomanufacturing Workflow
        • U.S. Next-gen Biomanufacturing Market, by Application
          • Monoclonal Antibodies
          • Vaccines
          • Hormones
          • Recombinant Proteins
          • Other Applications
        • U.S. Next-gen Biomanufacturing Market, by End User
          • Biopharmaceutical Companies
          • Research Institutions
          • CMOs/CDMOs
      • Canada
        • Canada Next-gen Biomanufacturing Market, by Workflow Type
          • Continuous Upstream Biomanufacturing Workflow
          • Single-Use Upstream Biomanufacturing Workflow
          • Downstream Biomanufacturing Workflow
        • Canada Next-gen Biomanufacturing Market, by Application
          • Monoclonal Antibodies
          • Vaccines
          • Hormones
          • Recombinant Proteins
          • Other Applications
        • Canada Next-gen Biomanufacturing Market, by End User
          • Biopharmaceutical Companies
          • Research Institutions
          • CMOs/CDMOs
      • Mexico
        • Mexico Next-gen Biomanufacturing Market, by Workflow Type
          • Continuous Upstream Biomanufacturing Workflow
          • Single-Use Upstream Biomanufacturing Workflow
          • Downstream Biomanufacturing Workflow
        • Mexico Next-gen Biomanufacturing Market, by Application
          • Monoclonal Antibodies
          • Vaccines
          • Hormones
          • Recombinant Proteins
          • Other Applications
        • Mexico Next-gen Biomanufacturing Market, by End User
          • Biopharmaceutical Companies
          • Research Institutions
          • CMOs/CDMOs
    • Europe
      • Europe Next-gen Biomanufacturing Market, by Workflow Type
        • Continuous Upstream Biomanufacturing Workflow
        • Single-Use Upstream Biomanufacturing Workflow
        • Downstream Biomanufacturing Workflow
      • Europe Next-gen Biomanufacturing Market, by Application
        • Monoclonal Antibodies
        • Vaccines
        • Hormones
        • Recombinant Proteins
        • Other Applications
      • Europe Next-gen Biomanufacturing Market, by End User
        • Biopharmaceutical Companies
        • Research Institutions
        • CMOs/CDMOs
      • U. K.
        • U.K. Next-gen Biomanufacturing Market, by Workflow Type
          • Continuous Upstream Biomanufacturing Workflow
          • Single-Use Upstream Biomanufacturing Workflow
          • Downstream Biomanufacturing Workflow
        • U.K. Next-gen Biomanufacturing Market, by Application
          • Monoclonal Antibodies
          • Vaccines
          • Hormones
          • Recombinant Proteins
          • Other Applications
        • U.K. Next-gen Biomanufacturing Market, by End User
          • Biopharmaceutical Companies
          • Research Institutions
          • CMOs/CDMOs
      • France
        • France Next-gen Biomanufacturing Market, by Workflow Type
          • Continuous Upstream Biomanufacturing Workflow
          • Single-Use Upstream Biomanufacturing Workflow
          • Downstream Biomanufacturing Workflow
        • France Next-gen Biomanufacturing Market, by Application
          • Monoclonal Antibodies
          • Vaccines
          • Hormones
          • Recombinant Proteins
          • Other Applications
        • France Next-gen Biomanufacturing Market, by End User
          • Biopharmaceutical Companies
          • Research Institutions
          • CMOs/CDMOs
      • Germany
        • Germany Next-gen Biomanufacturing Market, by Workflow Type
          • Continuous Upstream Biomanufacturing Workflow
          • Single-Use Upstream Biomanufacturing Workflow
          • Downstream Biomanufacturing Workflow
        • Germany Next-gen Biomanufacturing Market, by Application
          • Monoclonal Antibodies
          • Vaccines
          • Hormones
          • Recombinant Proteins
          • Other Applications
        • Germany Next-gen Biomanufacturing Market, by End User
          • Biopharmaceutical Companies
          • Research Institutions
          • CMOs/CDMOs
      • Italy
        • Italy Next-gen Biomanufacturing Market, by Workflow Type
          • Continuous Upstream Biomanufacturing Workflow
          • Single-Use Upstream Biomanufacturing Workflow
          • Downstream Biomanufacturing Workflow
        • Italy Next-gen Biomanufacturing Market, by Application
          • Monoclonal Antibodies
          • Vaccines
          • Hormones
          • Recombinant Proteins
          • Other Applications
        • Italy Next-gen Biomanufacturing Market, by End User
          • Biopharmaceutical Companies
          • Research Institutions
          • CMOs/CDMOs
      • Spain
        • Spain Next-gen Biomanufacturing Market, by Workflow Type
          • Continuous Upstream Biomanufacturing Workflow
          • Single-Use Upstream Biomanufacturing Workflow
          • Downstream Biomanufacturing Workflow
        • Spain Next-gen Biomanufacturing Market, by Application
          • Monoclonal Antibodies
          • Vaccines
          • Hormones
          • Recombinant Proteins
          • Other Applications
        • Spain Next-gen Biomanufacturing Market, by End User
          • Biopharmaceutical Companies
          • Research Institutions
          • CMOs/CDMOs
      • Rest of Europe
        • Rest of Europe Next-gen Biomanufacturing Market, by Workflow Type
          • Continuous Upstream Biomanufacturing Workflow
          • Single-Use Upstream Biomanufacturing Workflow
          • Downstream Biomanufacturing Workflow
        • Rest of Europe Next-gen Biomanufacturing Market, by Application
          • Monoclonal Antibodies
          • Vaccines
          • Hormones
          • Recombinant Proteins
          • Other Applications
        • Rest of Europe Next-gen Biomanufacturing Market, by End User
          • Biopharmaceutical Companies
          • Research Institutions
          • CMOs/CDMOs
    • Asia Pacific
      • Asia Pacific Next-gen Biomanufacturing Market, by Workflow Type
        • Continuous Upstream Biomanufacturing Workflow
        • Single-Use Upstream Biomanufacturing Workflow
        • Downstream Biomanufacturing Workflow
      • Asia Pacific Next-gen Biomanufacturing Market, by Application
        • Monoclonal Antibodies
        • Vaccines
        • Hormones
        • Recombinant Proteins
        • Other Applications
      • Asia Pacific Next-gen Biomanufacturing Market, by End User
        • Biopharmaceutical Companies
        • Research Institutions
        • CMOs/CDMOs
      • China
        • China Next-gen Biomanufacturing Market, by Workflow Type
          • Continuous Upstream Biomanufacturing Workflow
          • Single-Use Upstream Biomanufacturing Workflow
          • Downstream Biomanufacturing Workflow
        • China Next-gen Biomanufacturing Market, by Application
          • Monoclonal Antibodies
          • Vaccines
          • Hormones
          • Recombinant Proteins
          • Other Applications
        • China Next-gen Biomanufacturing Market, by End User
          • Biopharmaceutical Companies
          • Research Institutions
          • CMOs/CDMOs
      • Japan
        • Japan Next-gen Biomanufacturing Market, by Workflow Type
          • Continuous Upstream Biomanufacturing Workflow
          • Single-Use Upstream Biomanufacturing Workflow
          • Downstream Biomanufacturing Workflow
        • Japan Next-gen Biomanufacturing Market, by Application
          • Monoclonal Antibodies
          • Vaccines
          • Hormones
          • Recombinant Proteins
          • Other Applications
        • Japan Next-gen Biomanufacturing Market, by End User
          • Biopharmaceutical Companies
          • Research Institutions
          • CMOs/CDMOs
      • Germany
        • Germany Next-gen Biomanufacturing Market, by Workflow Type
          • Continuous Upstream Biomanufacturing Workflow
          • Single-Use Upstream Biomanufacturing Workflow
          • Downstream Biomanufacturing Workflow
        • Germany Next-gen Biomanufacturing Market, by Application
          • Monoclonal Antibodies
          • Vaccines
          • Hormones
          • Recombinant Proteins
          • Other Applications
        • Germany Next-gen Biomanufacturing Market, by End User
          • Biopharmaceutical Companies
          • Research Institutions
          • CMOs/CDMOs
      • India
        • India Next-gen Biomanufacturing Market, by Workflow Type
          • Continuous Upstream Biomanufacturing Workflow
          • Single-Use Upstream Biomanufacturing Workflow
          • Downstream Biomanufacturing Workflow
        • India Next-gen Biomanufacturing Market, by Application
          • Monoclonal Antibodies
          • Vaccines
          • Hormones
          • Recombinant Proteins
          • Other Applications
        • India Next-gen Biomanufacturing Market, by End User
          • Biopharmaceutical Companies
          • Research Institutions
          • CMOs/CDMOs
      • South Korea
        • South Korea Next-gen Biomanufacturing Market, by Workflow Type
          • Continuous Upstream Biomanufacturing Workflow
          • Single-Use Upstream Biomanufacturing Workflow
          • Downstream Biomanufacturing Workflow
        • South Korea Next-gen Biomanufacturing Market, by Application
          • Monoclonal Antibodies
          • Vaccines
          • Hormones
          • Recombinant Proteins
          • Other Applications
        • South Korea Next-gen Biomanufacturing Market, by End User
          • Biopharmaceutical Companies
          • Research Institutions
          • CMOs/CDMOs
      • South East Asia
        • South East Asia Next-gen Biomanufacturing Market, by Workflow Type
          • Continuous Upstream Biomanufacturing Workflow
          • Single-Use Upstream Biomanufacturing Workflow
          • Downstream Biomanufacturing Workflow
        • South East Asia Next-gen Biomanufacturing Market, by Application
          • Monoclonal Antibodies
          • Vaccines
          • Hormones
          • Recombinant Proteins
          • Other Applications
        • South East Asia Next-gen Biomanufacturing Market, by End User
          • Biopharmaceutical Companies
          • Research Institutions
          • CMOs/CDMOs
      • Rest of Asia Pacific
        • Rest of Asia Pacific Next-gen Biomanufacturing Market, by Workflow Type
          • Continuous Upstream Biomanufacturing Workflow
          • Single-Use Upstream Biomanufacturing Workflow
          • Downstream Biomanufacturing Workflow
        • Rest of Asia Pacific Next-gen Biomanufacturing Market, by Application
          • Monoclonal Antibodies
          • Vaccines
          • Hormones
          • Recombinant Proteins
          • Other Applications
        • Rest of Asia Pacific Next-gen Biomanufacturing Market, by End User
          • Biopharmaceutical Companies
          • Research Institutions
          • CMOs/CDMOs
    • Latin America
      • Latin America Next-gen Biomanufacturing Market, by Workflow Type
        • Continuous Upstream Biomanufacturing Workflow
        • Single-Use Upstream Biomanufacturing Workflow
        • Downstream Biomanufacturing Workflow
      • Latin America Next-gen Biomanufacturing Market, by Application
        • Monoclonal Antibodies
        • Vaccines
        • Hormones
        • Recombinant Proteins
        • Other Applications
      • Latin America Next-gen Biomanufacturing Market, by End User
        • Biopharmaceutical Companies
        • Research Institutions
        • CMOs/CDMOs
      • Brazil
        • Brazil Next-gen Biomanufacturing Market, by Workflow Type
          • Continuous Upstream Biomanufacturing Workflow
          • Single-Use Upstream Biomanufacturing Workflow
          • Downstream Biomanufacturing Workflow
        • Brazil Next-gen Biomanufacturing Market, by Application
          • Monoclonal Antibodies
          • Vaccines
          • Hormones
          • Recombinant Proteins
          • Other Applications
        • Brazil Next-gen Biomanufacturing Market, by End User
          • Biopharmaceutical Companies
          • Research Institutions
          • CMOs/CDMOs
      • Argentina
        • Argentina Next-gen Biomanufacturing Market, by Workflow Type
          • Continuous Upstream Biomanufacturing Workflow
          • Single-Use Upstream Biomanufacturing Workflow
          • Downstream Biomanufacturing Workflow
        • Argentina Next-gen Biomanufacturing Market, by Application
          • Monoclonal Antibodies
          • Vaccines
          • Hormones
          • Recombinant Proteins
          • Other Applications
        • Argentina Next-gen Biomanufacturing Market, by End User
          • Biopharmaceutical Companies
          • Research Institutions
          • CMOs/CDMOs
      • Rest of Latin America
        • Rest of Latin America Next-gen Biomanufacturing Market, by Workflow Type
          • Continuous Upstream Biomanufacturing Workflow
          • Single-Use Upstream Biomanufacturing Workflow
          • Downstream Biomanufacturing Workflow
        • Rest of Latin America Next-gen Biomanufacturing Market, by Application
          • Monoclonal Antibodies
          • Vaccines
          • Hormones
          • Recombinant Proteins
          • Other Applications
        • Rest of Latin America Next-gen Biomanufacturing Market, by End User
          • Biopharmaceutical Companies
          • Research Institutions
          • CMOs/CDMOs
    • Middle East & Africa
      • Middle East & Africa Next-gen Biomanufacturing Market, by Workflow Type
        • Continuous Upstream Biomanufacturing Workflow
        • Single-Use Upstream Biomanufacturing Workflow
        • Downstream Biomanufacturing Workflow
      • Middle East & Africa Next-gen Biomanufacturing Market, by Application
        • Monoclonal Antibodies
        • Vaccines
        • Hormones
        • Recombinant Proteins
        • Other Applications
      • Middle East & Africa Next-gen Biomanufacturing Market, by End User
        • Biopharmaceutical Companies
        • Research Institutions
        • CMOs/CDMOs
      • GCC Countries
        • GCC Countries Next-gen Biomanufacturing Market, by Workflow Type
          • Continuous Upstream Biomanufacturing Workflow
          • Single-Use Upstream Biomanufacturing Workflow
          • Downstream Biomanufacturing Workflow
        • GCC Countries Next-gen Biomanufacturing Market, by Application
          • Monoclonal Antibodies
          • Vaccines
          • Hormones
          • Recombinant Proteins
          • Other Applications
        • GCC Countries Next-gen Biomanufacturing Market, by End User
          • Biopharmaceutical Companies
          • Research Institutions
          • CMOs/CDMOs
      • South Africa
        • South Africa Next-gen Biomanufacturing Market, by Workflow Type
          • Continuous Upstream Biomanufacturing Workflow
          • Single-Use Upstream Biomanufacturing Workflow
          • Downstream Biomanufacturing Workflow
        • South Africa Next-gen Biomanufacturing Market, by Application
          • Monoclonal Antibodies
          • Vaccines
          • Hormones
          • Recombinant Proteins
          • Other Applications
        • South Africa Next-gen Biomanufacturing Market, by End User
          • Biopharmaceutical Companies
          • Research Institutions
          • CMOs/CDMOs
      • Rest of Middle East & Africa
        • Rest of Middle East & Africa Next-gen Biomanufacturing Market, by Workflow Type
          • Continuous Upstream Biomanufacturing Workflow
          • Single-Use Upstream Biomanufacturing Workflow
          • Downstream Biomanufacturing Workflow
        • Rest of Middle East & Africa Next-gen Biomanufacturing Market, by Application
          • Monoclonal Antibodies
          • Vaccines
          • Hormones
          • Recombinant Proteins
          • Other Applications
        • Rest of Middle East & Africa Next-gen Biomanufacturing Market, by End User
          • Biopharmaceutical Companies
          • Research Institutions
          • CMOs/CDMOs
FAQ
Frequently Asked Question
  • The global Next-gen Biomanufacturing valued at USD 20.5 Billion in 2023 and is expected to reach USD 39.4 Billion in 2032 growing at a CAGR of 7.5%.

  • The prominent players in the market are Merck KGaA (Germany), Danaher Corp. (U.S.), Sartorius AG (Germany), Applikon Biotechnology B.V. (Netherlands), Getinge AB (Sweden), Thermo Fisher Scientific Inc. (U.S.), PBS Biotech Inc. (U.S.), bbi-biotech GmbH (Germany), Solaris Biotechnology (Italy), Meissner Corp. (U.S.), ESCO Group LLC (U.S.), GEA Group (Germany).

  • The market is project to grow at a CAGR of 7.5% between 2024 and 2032.

  • The driving factors of the Next-gen Biomanufacturing include

  • North America was the leading regional segment of the Next-gen Biomanufacturing in 2023.